PMID- 26087296 OWN - NLM STAT- MEDLINE DCOM- 20160324 LR - 20240118 IS - 1873-2518 (Electronic) IS - 0264-410X (Print) IS - 0264-410X (Linking) VI - 33 IP - 31 DP - 2015 Jul 17 TI - Congenital rubella syndrome (CRS) in Vietnam 2011-2012--CRS epidemic after rubella epidemic in 2010-2011. PG - 3673-7 LID - S0264-410X(15)00824-5 [pii] LID - 10.1016/j.vaccine.2015.06.035 [doi] AB - BACKGROUND: Rubella is endemic in Vietnam with epidemics occurring every 4-5 years. In 2011, Vietnam experienced the large nationwide rubella epidemic. During the rubella epidemic, many infants born with congenital rubella syndrome (CRS) were identified and reported from the neonatal units or cardiology departments of the national hospitals. To understand the burden of CRS, National Expanded Program on Immunization (NEPI) established sentinel CRS surveillance system. METHOD: Three national paediatric hospitals in Hanoi and Ho Chi Minh City (HCMC) were selected as CRS sentinel surveillance sites. Blood specimens from the infants were collected for rubella specific IgM and ELISA testing was performed at the national measles and rubella laboratory. RESULTS: From January 2011 to December 2012, 424 infants with suspected CRS were identified and reported. Among them 406 (96%) had specimens obtained, 284 (70%) cases were IgM positive including 279 laboratory confirmed CRS and 5 Congenital Rubella Infection (CRI). 13 cases were clinically confirmed and 127 (30%) were discarded. Total 292 infants were confirmed as CRS. Of the 292 infants with CRS, 69% of mothers had a history of "fever and rash" during pregnancy, of which 85% was in the first trimester. The most common clinical defects were congenital heart disease and cataract(s). However, 81.9% of the infants had a combination of major and minor signs and symptoms. Low birth weight in full term infants with confirmed CRS was observed in 114 infants (39%). CONCLUSIONS: The newly established CRS sentinel surveillance system documented the significant burden of CRS in Vietnam and provided evidence to the policy makers for the introduction of rubella containing vaccine (RCV) into Vietnam. This report highlights the importance of countries with rubella epidemic to establish CRS surveillance rapidly in order to support the introduction of RCV into the routine Expanded Programme on Immunization (EPI) immunization. CI - Copyright (c) 2015 Elsevier Ltd. All rights reserved. FAU - Toda, Kohei AU - Toda K AD - WHO Country Office, Hanoi, Viet Nam. Electronic address: todak@wpro.who.int. FAU - Reef, Susan AU - Reef S AD - Centers for Disease Control and Prevention, Atlanta, GA, USA. FAU - Tsuruoka, Miyuki AU - Tsuruoka M AD - WHO Country Office, Hanoi, Viet Nam. FAU - Iijima, Makiko AU - Iijima M AD - WHO Country Office, Hanoi, Viet Nam. FAU - Dang, Thanh Huyen AU - Dang TH AD - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. FAU - Duong, Thi Hong AU - Duong TH AD - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. FAU - Nguyen, Van Cuong AU - Nguyen VC AD - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. FAU - Nguyen, Tran Hien AU - Nguyen TH AD - National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam. LA - eng GR - 001/WHO_/World Health Organization/International GR - CC999999/ImCDC/Intramural CDC HHS/United States PT - Journal Article DEP - 20150615 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (Antibodies, Viral) RN - 0 (Immunoglobulin M) SB - IM MH - Adolescent MH - Adult MH - Antibodies, Viral/blood MH - Enzyme-Linked Immunosorbent Assay MH - *Epidemics MH - Epidemiological Monitoring MH - Female MH - Health Policy MH - Humans MH - Immunization Programs MH - Immunoglobulin M/blood MH - Infant MH - Infant, Newborn MH - Male MH - Pregnancy MH - Prevalence MH - Retrospective Studies MH - Rubella Syndrome, Congenital/*epidemiology MH - Vietnam/epidemiology MH - Young Adult PMC - PMC10792995 MID - NIHMS1919052 OTO - NOTNLM OT - CRS OT - CRS surveillance OT - Congenital rubella syndrome OT - RCV OT - Routine EPI immunization OT - Rubella COIS- Conflict of interest statement None of authors have financial or other conflict of interest. EDAT- 2015/06/19 06:00 MHDA- 2016/03/25 06:00 PMCR- 2024/01/17 CRDT- 2015/06/19 06:00 PHST- 2015/04/07 00:00 [received] PHST- 2015/06/02 00:00 [revised] PHST- 2015/06/04 00:00 [accepted] PHST- 2015/06/19 06:00 [entrez] PHST- 2015/06/19 06:00 [pubmed] PHST- 2016/03/25 06:00 [medline] PHST- 2024/01/17 00:00 [pmc-release] AID - S0264-410X(15)00824-5 [pii] AID - 10.1016/j.vaccine.2015.06.035 [doi] PST - ppublish SO - Vaccine. 2015 Jul 17;33(31):3673-7. doi: 10.1016/j.vaccine.2015.06.035. Epub 2015 Jun 15.